Why does an FDA complete response letter matter to investors?
Although companies are not legally required to disclose the contents of an FDA complete response letter, they typically do share at least some information with their shareholders in the spirit of transparency. These letters are important because they can tell you exactly what that new flagship product needs to launch and can give experienced investors in the pharmaceutical or related sectors an idea about how long it will take to get approval.
FDA complete response letters can also tell you if the bet you've made in your company's future is likely to pay off. For example, if XYZ Pharma was hyping an upcoming cholesterol drug that would allow customers to eat red meat all day without consequence, you might decide to invest due to that specific drug.
But if the FDA complete response letter to its application showed major deficiencies in things like drug testing, you might reconsider that investment or at least plan to dig in for the very long haul before seeing any return on your dollars. On the other hand, if the FDA complete response letter just said that the packaging had to include a more visible warning about side effects, you'd know that things may be about to get crazy, and perhaps you should buy more shares in that stock before they go sky-high on the news of its pending approval.